Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
909.32
-15.24 (-1.65%)
Official Closing Price
Updated: 4:10 PM EDT, Sep 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
99
100
Next >
Why Meta Platforms Stock Topped the Market Today
March 06, 2024
Investors were happy that the company had a generally uneventful Wednesday.
Via
The Motley Fool
Trillion-Dollar Threshold: The Next 3 Stocks Ready to Rise
March 06, 2024
With a trillion-dollar valuation in sight, these three growth companies have stocks ready to rise to meet the challenge.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
March 06, 2024
Via
Benzinga
Why Dexcom — And The Obesity Market — Could Benefit From This New FDA Win
March 06, 2024
The FDA granted Dexcom's Stelo a broad clearance, meaning people without diabetes can use it.
Via
Investor's Business Daily
Exposures
Product Safety
Escalating Demand for Obesity Drugs Creates Time-Sensitive Race for Eli Lilly, Novo Nordisk
March 06, 2024
Eli Lilly's strategic collaborations with outsourcing partners for Zepbound (tirzepatide) production. Challenges persist as Eli Lilly and Novo Nordisk address production bottlenecks amid rising...
Via
Benzinga
Eli Lilly and Co Options Trading: A Deep Dive into Market Sentiment
March 04, 2024
Via
Benzinga
Is It Too Late to Buy Eli Lilly Stock Now?
March 02, 2024
Eli Lilly stock is having a moment, but the company could easily continue soaring.
Via
The Motley Fool
Is Viking Therapeutics Stock a Better Buy Than Eli Lilly and Novo Nordisk After the Latest Weight-Loss Drug News?
March 06, 2024
A new player in the multibillion-dollar weight-loss drug market could be waiting in the wings.
Via
The Motley Fool
Why Dialysis Stocks DaVita, Fresenius Soared On Novo's Ozempic News
March 05, 2024
Novo Nordisk tested its diabetes and weight-loss drug in patients with chronic kidney disease.
Via
Investor's Business Daily
Prediction: Eli Lilly and Novo Nordisk Stock Could Just be Getting Started. Here's Why
March 05, 2024
Eli Lilly and Novo Nordisk dominate the diabetes market thanks to blockbuster medications Mounjaro, Ozempic, and Rybelsus.
Via
The Motley Fool
Better Weight Loss Drug Stock: Viking Therapeutics vs. Eli Lilly
March 05, 2024
One is a reigning champion, and the other is a burgeoning contender.
Via
The Motley Fool
Jim Cramer Says Nvidia, Eli Lilly, Novo Nordisk Are Not Overvalued: 'Will Be Ready To Buy If This Market Sells Off'
March 05, 2024
Cramer suggested that the upcoming labor report could potentially trigger a buying opportunity, predicting stronger figures than expected by Wall Street.
Via
Benzinga
A Closer Look at 18 Analyst Recommendations For Eli Lilly and Co
March 01, 2024
Via
Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $13,000 Today
March 01, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 04, 2024
Via
Benzinga
It’s Time! 3 Dodgy Pharma Stocks to Sell in February
March 04, 2024
Explore pharma stocks to sell in February: Eli Lilly, Amgen, BioNTech face overvaluation, volatility, urging investor action.
Via
InvestorPlace
1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $1000. Is It a Buy Around $782?
March 04, 2024
There are two big reasons why Eli Lilly stock is as much as 5x more expensive than Pfizer.
Via
The Motley Fool
Here's How Much You'd Have If You Invested $10,000 in Eli Lilly Stock When Billionaire George Soros First Bought It
March 04, 2024
The tricky part would have been to not sell the pharmaceutical giant's shares when Soros did.
Via
The Motley Fool
This Is the Biggest Company Not in the "Magnificent Seven" -- but It Deserves to Be
March 04, 2024
It's in a distinctly different business than the "Magnificent Seven" companies, but it deserves the same attention.
Via
The Motley Fool
Better Blockbuster-Drug Stock: Novo Nordisk vs. Eli Lilly
March 03, 2024
This is a close contest, and it'll go on for at least a few more rounds.
Via
The Motley Fool
Better Buy: Eli Lilly vs. Viking Therapeutics
March 03, 2024
These two biotechs could eventually go head to head in a fast-growing market.
Via
The Motley Fool
3 Magnificent Growth Stocks to Buy in March
March 02, 2024
These three stocks have two important common denominators: the same industry and tremendous growth prospects.
Via
The Motley Fool
Why Novo Nordisk Stock Topped the Market Today
March 01, 2024
A favorite of both investors and analysts gets a boost from a bullish move by a pundit.
Via
The Motley Fool
Record-High S&P 500 Propels SPY ETF To $500-Billion Milestone, Nvidia Tops $2 Trillion, Broadcom Surpasses Tesla
March 01, 2024
U.S. stock market continues bull run, hitting record highs for S&P 500 and Nasdaq 100. SPY ETF surpasses $500 billion AUM, with other companies also reaching milestones.
Via
Benzinga
Topics
ETFs
Stocks
Exposures
US Equities
Eli Lilly's Commercial Moat, Competitor Landscape: BofA Emphasizes Strength in Incretin Space, Undervalued Assets
March 01, 2024
Eli Lilly: BofA Securities rates it a top pick in Biopharma, with a YTD performance of +29%. Analysts highlight undervalued opportunities in heart disease, sleep apnea, and liver disease. Price target...
Via
Benzinga
Stock Market Rally At Highs After Big Earnings, Inflation Data: Weekly Review
March 01, 2024
The Nasdaq is on the cusp of setting a record high.
Via
Investor's Business Daily
Topics
Economy
Exposures
Interest Rates
Eli Lilly Stock And The Road To 1,000: Weight-Loss Drugs Could Generate $81 Billion
March 01, 2024
Wall Street isn't properly taking into account Lilly's next-generation drugs, an analyst says.
Via
Investor's Business Daily
3 Healthcare Stocks That Have Outperformed Nvidia Since 2022
March 01, 2024
The healthcare sector is no slouch when it comes to top-performing growth stocks.
Via
The Motley Fool
Got $200? 2 Dividend Stocks to Buy and Hold Forever
March 01, 2024
Trust these two real estate stocks to be attractively priced and proven performers.
Via
The Motley Fool
2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years
March 01, 2024
It will take a lot, but this goal isn't out of reach for these stocks.
Via
The Motley Fool
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.